UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 127

Sortiert nach

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

The New England journal of medicine, 2014-07, Vol.371 (2), p.130-139

2014

Link zum Volltext

Verfügbarkeit prüfen

An RKHS Formulation of the Inverse Regression Dimension-Reduction Problem

The Annals of statistics, 2009-04, Vol.37 (2), p.726-755

2009

Link zum Volltext

Verfügbarkeit prüfen

Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: Results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee

Pain (Amsterdam), 2014-07, Vol.155 (7), p.1245-1252

2014

Link zum Volltext

Verfügbarkeit prüfen

Anisotropy in creep-aging behavior of Al–Li alloy under different stress levels: experimental and constitutive modeling

Journal of materials research and technology, 2022-09, Vol.20, p.3456-3470

2022

Link zum Volltext

Verfügbarkeit prüfen

Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies

The Journal of dermatological treatment, 2024-12, Vol.35 (1), p.2310633-2310633

2024

Link zum Volltext

Verfügbarkeit prüfen

Wear resistant aluminum alloy - B4C composites fabricated by rheo-casting and rolling process

Materials research express, 2020-05, Vol.7 (5), p.056525

2020

Link zum Volltext

Verfügbarkeit prüfen

First-in-Human Study of REGN668/SAR231893 (IL-4Rα mAb): Safety, Tolerability and Biomarker Results of a Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Volunteers

Journal of allergy and clinical immunology, 2013-02, Vol.131 (2), p.AB158-AB158

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy Of Dupilumab Versus Placebo For Moderate-To-Severe Atopic Dermatitis In Patients Using Topical Corticosteroids (TCS): Greater Efficacy Observed With Concomitant Therapy Compared To TCS Alone

Journal of allergy and clinical immunology, 2014-02, Vol.133 (2), p.AB192-AB192

2014

Link zum Volltext

Verfügbarkeit prüfen

Visual and quantitative evaluation of crack bonding rate of self-healing mortars based on volumetric strain analysis

Journal of cleaner production, 2024-04, Vol.450, p.141928, Article 141928

2024

Link zum Volltext

Verfügbarkeit prüfen

Dupilumab Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study

Journal of allergy and clinical immunology, 2014-02, Vol.133 (2), p.AB404-AB404

2014

Link zum Volltext

Verfügbarkeit prüfen

Chloride-ion-triggered microcapsule for self-suppression of capillary suction in cement paste

Cement & concrete composites, 2023-08, Vol.141, p.105144, Article 105144

2023

Link zum Volltext

Verfügbarkeit prüfen

A tuned triboelectric nanogenerator using a magnetic liquid for low-frequency vibration energy harvesting

Nanoscale, 2024-01, Vol.16 (4), p.1915-1923

2024

Link zum Volltext

Verfügbarkeit prüfen

Interfacial mechanical bond characterization between cement pastes and porous aggregates through a coupled XCT and DVC technique

Cement & concrete composites, 2023-09, Vol.142, p.105158, Article 105158

2023

Link zum Volltext

Verfügbarkeit prüfen

396 Rapid, substantial and sustained reduction of itch in adults with atopic dermatitis applying ruxolitinib cream 1.5% (SCRATCH-AD)

British journal of dermatology (1951), 2023-06, Vol.188 (Supplement_3)

2023

Link zum Volltext

Verfügbarkeit prüfen

35163 Ruxolitinib cream provided progressive improvement in patients with atopic dermatitis who did not achieve Investigator’s Global Assessment treatment success at week 8: Pooled results from 2 phase 3 studies

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB202-AB202

2022

Link zum Volltext

Verfügbarkeit prüfen

44103 Ruxolitinib Cream Monotherapy Use Demonstrates Maintenance of Disease and Symptom Control With Use As Needed in Adults and Adolescents With Atopic Dermatitis: Pooled Analysis From the Long Term Safety Periods of Two Phase 3 Studies

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB84-AB84

2023

Link zum Volltext

Verfügbarkeit prüfen

Community Versus Academic Practice in Essential Thrombocythemia and Myelofibrosis: Differences in Clinical Characteristics, Diagnosis, Treatment Patterns, and Symptom Burden (Analysis of Data from the MOST Study)

Blood, 2021-11, Vol.138 (Supplement 1), p.1497-1497

2021

Link zum Volltext

Verfügbarkeit prüfen

Influence of component damage on the mechanical performance of bracket set joints in ancient timber structures

European journal of environmental and civil engineering, 2022-06, Vol.26 (8), p.3258-3275

2022

Link zum Volltext

Verfügbarkeit prüfen

34794 Long-term safety and disease control of ruxolitinib cream among Black or African American patients with atopic dermatitis: Pooled results from 2 phase 3 studies

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB180-AB180

2022

Link zum Volltext

Verfügbarkeit prüfen

Patient-reported outcomes of patients with myelofibrosis or essential thrombocythemia enrolled in the MOST study

Leukemia & lymphoma, 2022-11, Vol.63 (13), p.3138-3153

2022

Link zum Volltext

Verfügbarkeit prüfen

To Treat or Not to Treat? Understanding Treatment Patterns in Patients with Lower-Risk Myelofibrosis at the Time of Enrollment in the MOST Study

Blood, 2020-11, Vol.136 (Supplement 1), p.49-51

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical Characteristics and Treatment Patterns By Risk Stratification in Patients with Essential Thrombocythemia: An Analysis of the MOST Study

Blood, 2020-11, Vol.136 (Supplement 1), p.12-13

2020

Link zum Volltext

Verfügbarkeit prüfen

Investigating mechanism for mortar-porous aggregate interfacial bond improvement based on coupled XCT-DVC analysis

Journal of Building Engineering, 2023-12, Vol.80, p.107952, Article 107952

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies

Journal of the American Academy of Dermatology, 2023-05, Vol.88 (5), p.1008-1016

2023

Link zum Volltext

Verfügbarkeit prüfen

43912 Facial Vitiligo Area Scoring Index Response Maintenance or Shift During 52 Weeks of Ruxolitinib Cream Treatment for Vitiligo: Pooled Analysis of the TRuE-V Phase 3 Studies

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB48-AB48

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(116)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(80)
Life Sciences & Biomedicine
(34)
Technology
(33)
Physical Sciences
(25)
Humans
(18)
Engineering
(16)
Materials Science
(15)
Male
(9)
Female
(8)
Materials Science, Multidisciplinary
(8)
Chemistry
(7)
Engineering, Electrical & Electronic
(7)
Mathematics
(7)
Animals
(6)
Biochemistry & Molecular Biology
(6)
Geology
(6)
Geosciences, Multidisciplinary
(6)
Statistics & Probability
(6)
Adult
(5)
Agriculture
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

An RKHS Formulation of the Inverse Regression Dimension-Reduction Problem

Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: Results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee

Anisotropy in creep-aging behavior of Al–Li alloy under different stress levels: experimental and constitutive modeling

Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies

Wear resistant aluminum alloy - B4C composites fabricated by rheo-casting and rolling process

First-in-Human Study of REGN668/SAR231893 (IL-4Rα mAb): Safety, Tolerability and Biomarker Results of a Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Volunteers

Safety and Efficacy Of Dupilumab Versus Placebo For Moderate-To-Severe Atopic Dermatitis In Patients Using Topical Corticosteroids (TCS): Greater Efficacy Observed With Concomitant Therapy Compared To TCS Alone

Visual and quantitative evaluation of crack bonding rate of self-healing mortars based on volumetric strain analysis

Dupilumab Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study

Chloride-ion-triggered microcapsule for self-suppression of capillary suction in cement paste

A tuned triboelectric nanogenerator using a magnetic liquid for low-frequency vibration energy harvesting

Interfacial mechanical bond characterization between cement pastes and porous aggregates through a coupled XCT and DVC technique

396 Rapid, substantial and sustained reduction of itch in adults with atopic dermatitis applying ruxolitinib cream 1.5% (SCRATCH-AD)

35163 Ruxolitinib cream provided progressive improvement in patients with atopic dermatitis who did not achieve Investigator’s Global Assessment treatment success at week 8: Pooled results from 2 phase 3 studies

44103 Ruxolitinib Cream Monotherapy Use Demonstrates Maintenance of Disease and Symptom Control With Use As Needed in Adults and Adolescents With Atopic Dermatitis: Pooled Analysis From the Long Term Safety Periods of Two Phase 3 Studies

Community Versus Academic Practice in Essential Thrombocythemia and Myelofibrosis: Differences in Clinical Characteristics, Diagnosis, Treatment Patterns, and Symptom Burden (Analysis of Data from the MOST Study)

Influence of component damage on the mechanical performance of bracket set joints in ancient timber structures

34794 Long-term safety and disease control of ruxolitinib cream among Black or African American patients with atopic dermatitis: Pooled results from 2 phase 3 studies

Patient-reported outcomes of patients with myelofibrosis or essential thrombocythemia enrolled in the MOST study

To Treat or Not to Treat? Understanding Treatment Patterns in Patients with Lower-Risk Myelofibrosis at the Time of Enrollment in the MOST Study

Clinical Characteristics and Treatment Patterns By Risk Stratification in Patients with Essential Thrombocythemia: An Analysis of the MOST Study

Investigating mechanism for mortar-porous aggregate interfacial bond improvement based on coupled XCT-DVC analysis

Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies

43912 Facial Vitiligo Area Scoring Index Response Maintenance or Shift During 52 Weeks of Ruxolitinib Cream Treatment for Vitiligo: Pooled Analysis of the TRuE-V Phase 3 Studies

Suchergebnisse filtern